Your browser doesn't support javascript.
loading
Th1-related disease development during omalizumab treatment: Two cases with severe asthma.
Hayashi, Hiroaki; Fukutomi, Yuma; Mitsui, Chihiro; Watai, Kentaro; Tomita, Yasuhiro; Kamide, Yosuke; Sekiya, Kiyoshi; Tsuburai, Takahiro; Horita, Ayako; Saito, Ikuo; Hasegawa, Yoshinori; Taniguchi, Masami.
Afiliação
  • Hayashi H; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Fukutomi Y; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
  • Mitsui C; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
  • Watai K; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
  • Tomita Y; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kamide Y; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
  • Sekiya K; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
  • Tsuburai T; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
  • Horita A; Department of Pathology, Sagamihara National Hospital, Sagamihara, Japan.
  • Saito I; Department of Pathology, Sagamihara National Hospital, Sagamihara, Japan.
  • Hasegawa Y; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Taniguchi M; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan. Electronic address: m-taniguchi@sagamihara-hosp.gr.jp.
Allergol Int ; 67(3): 405-407, 2018 Jul.
Article em En | MEDLINE | ID: mdl-29191372
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Células Th1 / Antiasmáticos / Omalizumab Tipo de estudo: Diagnostic_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Células Th1 / Antiasmáticos / Omalizumab Tipo de estudo: Diagnostic_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article